High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial (Q71572173)
Jump to navigation
Jump to search
scientific article published on 01 December 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial |
scientific article published on 01 December 1995 |
Statements
High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial (English)
Schrier DM
Stemmer SM
Johnson T
Kasliwal R
Lear J
Matthes S
Taffs S
Dufton C
Glenn SD
1 December 1995